The average one-year price target for Inspire Medical Systems (NYSE: INSP) has been raised to $144.32 per share, marking a 12.65% increase from the previous estimate of $128.11 as of December 3, 2025. This new target is an average from a range of analyst estimates, which vary from a low of $81.81 to a high of $189.00 per share. Notably, this average price target signifies a 49.49% increase from the latest reported closing price of $96.54 per share.
As of now, 730 funds or institutions hold positions in Inspire Medical Systems, a decrease of 10.87% from the last quarter, equating to 89 fewer owners. Total institutionally-owned shares fell by 8% to 39.624 million shares. The average portfolio weight dedicated to INSP has increased by 17.36% to 0.21%, while the put/call ratio stands at 1.32, indicating a bearish sentiment among traders.
Several notable shareholders include iShares Core S&P Small-Cap ETF, which holds 1.757 million shares (6.05% ownership), down 4.38% from the previous quarter; Citadel Advisors, increasing its stake by 99.50% to 1.748 million shares; and Deerfield Management, which boosted its holding by 86.64% to 1.048 million shares.
